Randox Laboratories

Randox Laboratories is a company in the in vitro diagnostics industry, developing diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. Randox develops, manufactures and markets diagnostic reagents and equipment for laboratory medicine, with a distribution network of 145 countries.[2][3]

Randox Laboratories
Private limited company
Founded1982
FounderPeter FitzGerald
Headquarters
Crumlin, County Antrim
,
United Kingdom
Number of locations
145 countries
Revenue £118,000,000 (2018)[1]
£167,000 (2018)
Total assets £47,700,000 (2018)
Number of employees
1500
Websitewww.randox.com

It is the official sponsor of the Randox Health Grand National from 2017.

Company profile

Randox was established in 1982 by its Managing Director, Dr Peter FitzGerald in Crumlin, and has since expanded globally.[4]

Randox manufactures more clinical diagnostic products than any other company in the world. It invests around 25% of profits into R&D, and almost a quarter of its staff are research scientists and engineers.[5]

Following the development of Randox Health - the first public facing division - the company became the title sponsor of the Randox Health Grand National.

Research and development

Beginning with a team of six employees, the company now has 1500 employees around the world. It is now moving into the Randox Science Park, a 45-acre R&D and manufacturing site housed on the former Massereene Barracks.

It has also recently invested €25m in developing a site in Dungloe, Donegal. Randox Teoranta aims to create more than 470 jobs in research, engineering and life sciences by 2020.

Randox's range of reagents covers many different techniques such as colorimetric, UV and immunoturbidimetric methods. As a result of heavy investment in R&D, Randox's portfolio has grown to provide a wider variety of reagents.

Randox has become a leading specialist in developing dedicated reagents to work on competitor systems, including Dimension and Hitachi.[6]

Products

Biochip array technology

Randox developed the world's first biochip array technology (BAT) in 2002. BAT is a multi-analyte testing platform which allows simultaneous quantitative or qualitative detection of a wide range of analytes from a single patient sample. It screens biological samples in a rapid, accurate and easy-to-use format. £180 million was invested in research and development of BAT.

With the development of the biochip, analysers were created to handle the biochip in a high throughput routine laboratory. The analyser range expanded from the evidence, to include the evidence evolution, evidence investigator and evidence multistat.[7]

Clinical chemistry analysers

Randox's range of clinical chemistry analysers, the RX Series, accommodates low- to high-throughput laboratories. The RX monza, RX daytona, RX daytona plus, RX imola, RX Monaco and RX suzuka are marketed as 'An attempt to consolidate a laboratory's requirements onto one platform'. The throughput of the range varies, with the RX monza having the capability of up to 10,000 tests per year and the RX suzuka having up to 1,000,000 tests per year.[8][9][10]

Quality control

Randox is the 3rd largest manufacturer of Quality Controls and Calibrators in the world. They specialise in third party controls that combine lots of analytes in a single control with the aim of consolidation. Covering over 390 parameters the Acusera branded portfolio of QC supplies 60,000 customers worldwide with QC material. Principle control products include Clinical Chemistry, Immunoassay, Urine, Cardiac and many more as well numerous other research based areas.[11]

Acusera 24.7 Live Online is an inter-laboratory data management programme, with the purpose of supporting the Acusera range of controls.[11][12]

RIQAS

Randox International Quality Assessment Scheme (RIQAS) is the external quality assessment (EQA) scheme supplied by Randox. RIQAS is the largest international EQA scheme with more than 35,000 laboratory participants in over 123 countries. There are currently 32 programmes available spanning most areas of clinical testing.[13] RIQAS is also ISO 13485 and UKAS accredited.[14][15]

Controversies

Coronavirus testing contract

The company has been awarded a £133 million contract by The Department of Health and Social Care (DHSC) without having to compete for a tender. When asked if Owen Paterson had lobbied on behalf of the company a spokesman for DHSC said they were “unable to comment on the personnel matters of other organisations”.[16]

On 7th August 2020, the United Kingdom Medicines and Healthcare Products Regulatory Agency requested Randox to recall the Randox COVID-19 Home Testing Kit due to safety concerns in a measure it described as precautionary.[17]

Data tampering

In February 2017, two Randox employees were arrested on suspicion of perverting the course of justice amid allegations of data tampering within Randox Testing Services, used by many Police Forces in England and Wales for forensic toxicology. Randox acquired this laboratory in Manchester from Trimega laboratories which went into administration in 2014.[18] As of November 2017, around 50 criminal prosecutions for driving offences had been dropped in what BBC home affairs correspondent, Danny Shaw, described as "the biggest forensic science scandal in the UK for decades".[19] Police forces have begun reviewing over 10,000 criminal cases that may be affected by the alleged data manipulation, including sexual and violent crimes.[20]

Owen Paterson

In March 2019 it was reported that former cabinet minister Owen Paterson, who was a consultant to Randox Laboratories, had helped to lobby the government[21] to seek contracts for them. This violates rules stating that an MP may not lobby on behalf of a paying client.

Notes and references
  1. "Randox: Healthcare diagnostics group returns to profit". BBC. BBC. Retrieved 30 June 2020.
  2. 18 March 2011 – Foster announces 242 new jobs at Randox Laboratories | Northern Ireland Executive. Northernireland.gov.uk (18 March 2011).
  3. Proteome Sciences Licenses Stroke Biomarkers to Randox Archived 26 January 2013 at Archive.today. IVD Technology (5 April 2012).
  4. The Friday Interview – Peter Fitz-Gerald, Randox Laboratories – IDA Ireland Investment Promotion Agency Archived 31 March 2013 at the Wayback Machine. Idaireland.com.
  5. Randox Laboratories: the future of healthcare – Personal Care Magazine. Pathologyinpractice.com.
  6. Diagnostic Reagents – Randox Laboratories. Randox.com.
  7. Randox Laboratories. Randox.com.
  8. "Archived copy". Archived from the original on 3 April 2011. Retrieved 22 September 2009.CS1 maint: archived copy as title (link)
  9. Clinical Chemistry Analysers – RX series – Randox Laboratories. Randox.com.
  10. Randox Laboratories. Randox.com.
  11. Interlaboratory Data Management – QC Software – Acusera 24.7 – Randox Laboratories Archived 28 July 2012 at the Wayback Machine. Randox.com.
  12. Randox Laboratories. Randox.com.
  13. EQA schemes – RIQAS – Largest Global EQA Providers – Randox Laboratories. Randox.com.
  14. EQA/Proficiency Testing Scheme- EQA- Proficiency Testing Archived 28 December 2012 at the Wayback Machine. RIQAS.
  15. http://www.ukas.org/AccredationOthers/schedules/0010Proficiency%20Testing%20Single.pdf
  16. Neate, Rupert; Garside, Juliette; Lawrence, Felicity; Evans, Rob (11 May 2020). "Healthcare firm advised by Owen Paterson won £133m coronavirus testing contract unopposed". The Guardian. ISSN 0261-3077. Retrieved 11 May 2020.
  17. United Kingdom Department of Health and Social Care (7 August 2020). "Update on Randox test kits". gov.uk. Retrieved 8 August 2020.
  18. "Randox expands toxicology service by buying Manchester lab". BBC News. 1 May 2014. Retrieved 18 June 2018.
  19. "Killer drug-drivers' conviction quash bid". BBC News. 22 November 2017. Retrieved 27 January 2018.
  20. Devlin, Hannah; Dodd, Vikram (21 November 2017). "Police review 10,000 cases in forensics data 'manipulation' inquiry". the Guardian. Retrieved 27 January 2018.
  21. Evans, Robb; Pegg, David; Lawrence, Felicity (8 April 2019). "MP Owen Paterson lobbied government for firm he worked for". The Guardian. Retrieved 3 September 2019.
gollark: Or trees/plants, which have the convenient feature of automatically generating interest.
gollark: Other fun idea: hydrogen (gradually diffuses away).
gollark: One of the interesting features of, say, uranium currency, is that it disinceitivizes putting large amounts of wealth in one place.
gollark: What does consciousness actually *do*, though?
gollark: I don't think "deterministic generation of choices and probabilities, random picking of one" is free will *either*.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.